140 results
Page 4 of 7
8-K
EX-99.2
nlyfr8ef p9k0bd
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
EX-2.1
kqtjxx17oyc9lm3da
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
EX-99.1
56epb
10 Nov 21
Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates
4:05pm
8-K
EX-99.1
s9l xninix
10 Aug 21
Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update
4:11pm
8-K
EX-99.1
8ez52 2ft1xeiqdt1t
12 Jul 21
Regulation FD Disclosure
4:00pm
8-K
EX-99.1
gkhljkh49a
11 Jun 21
Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease
7:00am
8-K
EX-99.1
lhb t11u5t2anzqtfj
10 Jun 21
Regulation FD Disclosure
11:13am
8-K
EX-99.1
sp2ik jxchwc
7 Jun 21
Regulation FD Disclosure
3:13pm
8-K
EX-99.1
f7mws1u
13 May 21
Equillium Reports First Quarter 2021 Financial Results and Provides Clinical Development Update
4:13pm
8-K
EX-99.1
nripfklzf3be9s
30 Mar 21
Equillium Announces Favorable Data From Phase 1b EQUALISE Study in Systemic Lupus Erythematosus Patients
4:52pm
8-K
EX-99.1
cuwmkdsz5s
24 Mar 21
Equillium Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development Update
4:10pm
8-K
EX-99.1
43fmfrnm8pe
15 Mar 21
Regulation FD Disclosure
8:02am
8-K
EX-99.1
1o4h b2dau26
9 Mar 21
Regulation FD Disclosure
7:00am
8-K
EX-99.2
p503xq6bc8yp h8r4
12 Feb 21
Regulation FD Disclosure
3:05pm
8-K
EX-99.1
lndzuvxcqe9 or0
4 Feb 21
Equillium Announces Pricing of $30 Million Registered Direct Offering
8:10am
424B5
lqzpd5ikg2
4 Feb 21
Prospectus supplement for primary offering
8:07am
8-K
EX-99.1
d4st6u6
21 Dec 20
Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of
8:06am
8-K
EX-99.1
jpldfy 5q9gv2eaz
7 Dec 20
Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell
9:24am